Balance Sheet
Cash Flow Statement
AmortizationAmortizationAmortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quantum Biopharma (QNTM) Cash from Operations (2019 - 2025)

Quantum Biopharma's Cash from Operations history spans 6 years, with the latest figure at 305598.0 for Q4 2025.

  • On a quarterly basis, Cash from Operations rose 63.43% to 305598.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 8237012.0, a 19.79% decrease, with the full-year FY2025 number at 8237012.0, down 19.79% from a year prior.
  • Cash from Operations hit 305598.0 in Q4 2025 for Quantum Biopharma, up from 1721476.0 in the prior quarter.
  • Over the last five years, Cash from Operations for QNTM hit a ceiling of 9398050.0 in Q2 2022 and a floor of 50340664.0 in Q4 2022.
  • Historically, Cash from Operations has averaged 4012061.69 across 4 years, with a median of 721122.0 in 2024.
  • Biggest five-year swings in Cash from Operations: soared 345.25% in 2021 and later plummeted 221.38% in 2025.
  • Tracing QNTM's Cash from Operations over 4 years: stood at 37401847.0 in 2021, then tumbled by 34.59% to 50340664.0 in 2022, then surged by 98.34% to 835762.0 in 2024, then soared by 63.43% to 305598.0 in 2025.
  • Business Quant data shows Cash from Operations for QNTM at 305598.0 in Q4 2025, 1721476.0 in Q3 2025, and 1949095.0 in Q2 2025.